title: The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency.
abstract: BACKGROUND
  21-hydroxylase deficiency (21OHD) is a common genetic disorder caused by mutations in the CYP21A2 gene, which encodes the adrenal 21-hydroxylase, microsomal P450c21. CYP21A2 gene mutations generally correlate well with impaired P450c21 enzymatic activity and the clinical findings in 21OHD, but occasional discrepancies between genotype and phenotype suggest the effects of modifier genes. Mutations in P450 oxidoreductase (POR), the protein that transfers electrons from reduced nicotinamide adenine dinucleotide phosphate to all microsomal P450s, can ameliorate the 21OHD phenotype and, therefore, could be a modifier gene.
  
  
  OBJECTIVE
  We sought to identify POR variants in patients with 21OHD having discordant phenotype and genotype, and to evaluate their effect on 21-hydroxylase activity.
  
  
  METHODS
  We determined the CYP21A2 genotypes of 313 Brazilian patients with 21OHD and correlated the genotype and phenotype. The POR gene was sequenced in 17 patients with discordant genotype and phenotype. Wild-type and A503V POR, and P450c21 were expressed in bacteria and reconstituted in vitro. Activities were assayed by conversion of [(14)C]progesterone to deoxycorticosterone and [(3)H]17-hydroxyprogesterone to 11-deoxycortisol, and assessed by thin layer chromatography and phosphorimaging.
  
  
  RESULTS
  The A503V POR variant was found in 10 of 30 alleles, the same ratio as in the normal population. There were no significant differences in Michaelis constant, maximum velocity and maximum velocity/Michaelis constant of 21-hydroxylase activity supported by wild-type and A503V POR.
  
  
  CONCLUSIONS
  The only POR missense polymorphism found in atypical 21OHD patients was A503V. Although A503V reduces P450c17 enzymatic activity, it does not influence P450c21 activity, indicating that POR A503V does not modify the 21OHD phenotype.
authors.affiliation: Department of Pediatrics, HSE-1401, 513 Parnassus Avenue, University of California-San Francisco, San Francisco, CA 94143-0978, USA.
authors.forename: Larissa G
authors.initials: LG
authors.lastname: Gomes
authors.forename: Ningwu
authors.initials: N
authors.lastname: Huang
authors.forename: Vishal
authors.initials: V
authors.lastname: Agrawal
authors.forename: Berenice B
authors.initials: BB
authors.lastname: Mendonça
authors.forename: Tania A S S
authors.initials: TA
authors.lastname: Bachega
authors.forename: Walter L
authors.initials: WL
authors.lastname: Miller
mesh_terms: D000312:Adrenal Hyperplasia, Congenital / Q000235:genetics*; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009251:NADPH-Ferrihemoprotein Reductase / Q000235:genetics* / Q000378:metabolism
chemical_list: D009251:NADPH-Ferrihemoprotein Reductase